Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | JNK-IN-8 | 3.0 | uM | 3 | VEGF | 570.0 | 50 | ||||
| RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 1035.0 | 79 | |
| N2586 | IKK16 | 2.0 | uM | 3 | VEGF | 1265.5 | 52 | ||||
| N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 1754.0 | 59 | |
| N2586 | Tofacitinib | 0.3 | uM | 3 | VEGF | 1685.0 | 57 | ||||
| N2586 | Ruxolitinib | 0.3 | uM | 3 | VEGF | 1276.0 | 61 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 1119.5 | 52 | |
| N2586 | JNK-IN-8 | 3.0 | uM | 3 | VEGF | 1282.0 | 75 | ||||
| RA2159 | IL-17A | 100 | ng/mL | 3 | VEGF | 880.0 | 61 | ||||
| RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 811.0 | 55 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 917.5 | 60 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 1254.0 | 53 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 947.0 | 54 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 918.0 | 66 | |
| N2586 | IL-17A | 100 | ng/mL | 3 | VEGF | 1545.0 | 67 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | VEGF | 1097.0 | 69 |